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Summary
Decliningmuscle strength is a core feature of aging. Several mech-
anisms have been postulated, including CCAAT ⁄ enhancer-binding
protein-beta (C ⁄ EBP-b)-triggered macrophage-mediated muscle
fiber regeneration after micro-injury, evidenced in a mouse
model. We aimed to identify in vivo circulating leukocyte gene
expression changes associated with muscle strength in the human
adult population. We undertook a genome-wide expression
microarray screen, using peripheral blood RNA samples from
InCHIANTI study participants (aged 30 and 104). Logged expres-
sion intensities were regressedwithmuscle strength usingmodels
adjusted for multiple confounders. Key results were validated by
real-time PCR. The Short Physical Performance Battery (SPPB) score
testedwalk speed, chair stand, and balance. CEBPB expression lev-
els were associated with muscle strength (b coefficient = 0.20560,
P = 1.03*10)6, false discovery rate q = 0.014). The estimated hand-
grip strength in 70-year-old men in the lowest CEBPB expression
tertile was 35.2 kg comparedwith 41.2 kg in the top tertile. CEBPB
expression was also associated with hip, knee, ankle, and shoul-
der strength and the SPPB score (P = 0.018). Near-study-wide asso-
ciations were also noted for TGF-b3 (P = 3.4*10)5, q = 0.12) and
CEBPD expression (P = 9.7*10)5, q = 0.18) but not for CEBPA
expression. We report here a novel finding that raised CEBPB
expression in circulating leukocyte-derived RNA samples in vivo is
associated with greater muscle strength and better physical per-
formance in humans. This association may be consistent with
mouse model evidence of CEBPB-triggered muscle repair: if this
mechanism is confirmed, it may provide a target for intervention
to protect and enhance agingmuscle.
Key words: inflammation; macrophage; mechanism; popula-
tion; regeneration; transcription.
Introduction
Aging is associated with a gradual loss of muscle mass and strength (Lang
et al., 2009) accompanied by increasing susceptibility to injury and
decreased capacity to repair and regenerate muscle (Peake et al., 2010).
Severe muscle loss (or ‘sarcopenia’) can eventually result in impairments
and limitations to physical functioning. Faulkner et al. (1995) argued that
‘everyday’ contraction-induced injury contributed to muscle aging (Faulk-
ner et al., 1990). Other suggested causes for sarcopenia include loss of
motor unit and local motor neuron changes, but also pathways with sys-
temic elements such as hormone ⁄ growth factor signaling, and inflamma-
tion (Lang et al., 2009).
Muscle repair after injury or change of use starts with an initial acute
inflammatory response (typically from 0 to 48 h) followed by a repair and
regeneration phase, typically lasting from 48 h to 10 days (Tidball, 2005).
Following injury, local muscle tissue secretes pro-inflammatory (Th1) cyto-
kines (in particular TNF-a and IFN-c, but also IL-1b, IL-6 and others; see
Fig. 1a for simplified representation of the pathways from the published
literature) that instigate an innate immune response. Neutrophil invasion
enhances inflammation at the injury site (Nguyen & Tidball, 2003; Tidball,
2005) and is followed by local migration of macrophages, monocytes
(St Pierre & Tidball, 1994), and T-helper type 1 (Th1) lymphocytes. Mono-
cytes are then available to differentiate into specific macrophage sub-
types (Arnold et al., 2007), which are essential for effective muscle
regeneration (Robertson et al., 1993).
At the late stage of the pro-inflammatory phase, there is increased pro-
duction of IL-4, IL-13, and transforming growth factor-beta (TGF-b) from
T-helper type 2 (Th2) lymphocytes; phagocytosis of necrotic tissue also
influences this change in phenotype (Arnold et al., 2007). These cyto-
kines inhibit the production of Th1 cytokines and initiate the accumula-
tion of alternatively activated (anti-inflammatory ⁄M2) macrophages,
which include wound-healing and regulatory phenotypes (Mosser &
Edwards, 2008), thereby promoting tissue repair (Villalta et al., 2009;
Fig. 1b). As inflammation is attenuated, myoblast differentiation is
induced and new muscle fibers are formed.
CCAAT-enhancer-binding protein-beta (C ⁄ EBP-b) has a pivotal role in
these processes. Ruffell et al. (2009) showed in a mouse model that dele-
tion of two CREB-binding sites from the CEBPB promoter prevented
C ⁄ EBP-b induction and prevented the transition from M1 to M2 macro-
phage-specific gene expression during muscle repair. In their model, the
pro-inflammatory response was unaffected, but muscle fiber regenera-
tion was severely compromised, with the injured area showing a fibrotic
appearance, with fewer, smaller, and calcified myofibers. Although
CEBPB is expressed at basal levels in M1 macrophages, significant (typi-
cally 10-fold) up-regulation of CEBPB above constitutive levels is required
for M2 activation, and therefore muscle repair (Bradley et al., 2003).
Another pathway suggested as pivotal in muscle regeneration is Wnt
signaling; age-related loss of muscle strength caused by increased fibrosis
was associated with increased systemic Wnt signaling in aged mice (Brack
et al., 2007). Conversely, others have found that Wnt signaling induced
the myogenic specification of resident myeloid stem cells during muscle
regeneration (Polesskaya et al., 2003); therefore, it is likely that an opti-
mal trade-off may be reached, but that it changes over the lifespan of an
organism.
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While muscle repair has been studied in depth ‘in vitro’ and in ani-
mal models, ‘in vivo’ human studies are intrinsically more difficult. In
theory, gene expression patterns could be studied in serial muscle
biopsies, but this would be too invasive and would interfere with
repair processes. In this study, we instead examined expression in
blood (leukocyte) samples collected with immediate stabilization of
RNA, so that results reflect in vivo mRNA expression. Blood-derived
white cell transcriptome studies have already proved valuable in identi-
fying signatures of major diseases and drug responses (Dumeaux et al.,
2010). Studying systemic factors in muscle strength may be particularly
informative, as experimental transplantation of old muscle to a young
rat host results in regeneration as marked as that seen in young
muscle, suggesting that circulating factors may be critical (Carlson &
Faulkner, 1989).
In this study, we aimed to test the relevance of CEBPB and other tran-
scripts to muscle strength in vivo. The InCHIANTI population study (http://
www.inchiantistudy.net) is particularly useful for this as it includes a wide
age range and muscle strength measures at multiple sites.
Results
Six hundred and ninety-eight people were included in the analysis, rang-
ing in age from 30 to 104 years (Table 1). Nearly 45% of the sample was
men, and 54% had been non-smokers. In linear models adjusted for mul-
tiple potential confounders (see Experimental procedures), CEBPB tran-
script expression emerged to be most strongly associated with handgrip
muscle strength: b coefficient = 0.20560, P = 1.03*10)6 (Table 2; for
table of top 250 regression results, see Table S1). CEBPB was also the only
transcript to reach study-wide significance, accounting for multiple statis-
tical testing of array data [false discovery rate (FDR) q-value = 0.014].
Associations with muscle strength for six other transcripts were likely to
be robust (i.e., with a FDR q-value < 0.2, indicating that more than 80%
of these are valid associations). Notable in these was TGF-b3
(P = 3.4*10-5, q = 0.12) and CEBPD expression (P = 9.7*10)5,
q = 0.18). Relatively little is known about the four other transcripts
(TAAR8, EXOC1, CBWD5, and CA433556–CD40L). There were no associ-
ations with other measured CEBP-transcripts, namely CEBPA, CEBPZ, CE-
BPG, and CEBPE (for all P > 0.18).
CEBPB expression and grip strength: effect sizes
We focused on CEBPB expression, being the only gene to reach study-
wide significance with muscle strength. First, we explored the associa-
tions between CEBPB expression and white blood cell counts. In regres-
sion models adjusted for the same terms as previously but testing each
white cell subtype separately, we found a strong negative association
between CEBPB expression and increasing lymphocyte percentage (stan-
dardized b = )0.50, P < 0.001) and a marginally less strong positive
association with increasing neutrophil percentage (standardized
b = 0.47, P < 0.001). There was no association with circulating mono-
cyte percentage. We tested the model for interactions between CEBPB
expression and lymphocyte percentage for handgrip muscle strength: the
interaction term was not significant (P = 0.250).
To provide estimates of the unadjusted effect sizes, we show the distri-
bution of handgrip muscle strength by tertile of CEBPB expression in men
and women separately (Fig. 2) for those in the middle tertile of both neu-
trophil and lymphocyte percentages (n = 160). Using our fully adjusted
models, we estimated grip strength for 70-year-old men or women
(Table 3). This showed similar results to the unadjusted data, with mean
handgrip strength in men in the highest CEBPB expression tertile being
41.2 kg compared with 35.2 kg in the bottom tertile. In women, there
was a similar spread of predicted mean grip strength (from 26.0 to
20.0 kg, respectively).
Advancing age is associated with lower handgrip strength (b = )0.5,
P < 1E-10) and separately with lower CEBPB expression (b = )0.15,
P < 1E-4); however, age (b = )0.04, P > 0.05) ceases to be significantly
(A) (B)
Fig. 1 Macrophage polarization during
muscle injury ⁄ repair. Macrophages have a
repertoire of phenotypes ranging from
classical activation to several alternative
activation states. These are generally termed
pro-inflammatory ⁄ M1 (a) and anti-
inflammatory ⁄ M2 (b), respectively. They are
functionally distinct, and the correct
differentiation at the right time is critical to
an effective regeneration process. Drawn
from the literature, this diagram represents
that main factors involved in the classical (a)
and alternative activation states (b) of
macrophages as the time from wounding
progresses. The review by Tidball & Villalta
(2010) was particularly informative. LDL,
low-density lipid; Th1, T-helper type 1 ⁄ pro-
inflammatory response; Th2, T-helper type
2 ⁄ anti-inflammatory response.
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associated with grip strength when CEBPB expression is included as an
explanatory covariate.
To confirm the microarray result, we re-measured CEBPB expression in
100 male InCHIANTI subjects. Very similar results were found plotting ter-
tile of CEBPB expression against grip strength (Fig. S1): those in the top
expression tertile had higher mean strength compared with those in the
bottom tertile (CEBPB expression correlation with handgrip strength,
P = 0.048, excluding five outlier values).
Associations with strength in other muscle systems and
with physical performance
We next examined associations between CEBPB expression and muscle
strength measured at other sites, in models adjusted as previously. There
were significant positive associations with measures at the knee, hip,
ankle, and shoulder (Table S2).
A critical question is whether the changes in muscle strength seen are
of functional significance. Those in the highest tertile of CEBPB expression
were far less likely to have impaired performance on the Short Physical
Performance Battery (SPPB) score (Table S3): the highest expression tertile
group had an odds ratio of 0.42 (95% CI, 0.20–0.86; P = 0.018) for hav-
ing impaired performance (SPPB score < 10, 22.35% of the sample).
There were trends for the three subscales, with a significant association
for walk speed impairment (OR = 0.33; 95% CI, 0.14–0.80; P = 0.014).
Muscle strength and physical activity
In post hoc sensitivity analyses, we explored whether the association of
CEBPB expression with muscle strength was explained by higher levels of
physical activity. Adjusting for seven levels of physical activity over the
previous 1 or 3 years had limited impact on the association between CE-
BPB expression and handgrip, which remained strongly significant
(b = 0.13; 95% CI, 0.06–0.19; P = 0.001; and b = 0.16; 95% CI, 0.09–
0.23; P < 0.001, respectively).
A potential mechanism underlying the CEBPB association
with muscle strength
To identify, as far as possible, the likely general mechanisms mediating
the CEBPB association with muscle strength, we searched the Gene
Ontology database (Ashburner et al., 2000) for pathways in which CEBPB
is involved; this yielded 16 results, most of which are inflammatory-
⁄ immune-related, including acute and chronic stages of inflammation,
response to stress and wound healing. Gene Ontology does not include a
specific pathway explicitly including both CEBPB and muscle, or macro-
phage activation states. A Gene Set Enrichment Analysis (see Experimen-
tal procedures), which determines whether sets of biologically related
genes are more strongly associated with grip strength than might occur
by chance, showed no significant associations (P-values > 0.05). A lead-
ing alternative pathway involved in muscle repair is WNT signaling, but
we found no evidence that b-catenin (downstream effector of Wnt)
expression was associated with grip strength in our leukocyte samples
(P > 0.05).
Discussion
Loss of muscle strength is a core feature of aging, and a range of poten-
tial local and systemic mechanisms have been proposed to explain it (Lang
et al., 2009). Among the more promising is the theory that contraction-
induced damage to muscle is common and associated with impaired
Table 1 Characteristics of the study sample
Study sample characteristics n (%)
Age (years)
30–65 163 (23.35)
66–85 444 (63.61)
86–104 91 (13.04)
Gender
Men 313 (44.84)
Women 385 (55.16)
Site
Greve 342 (49)
Bagno a Ripoli 356 (51)
Education
None ⁄ elementary 416 (59.61)
Secondary 93 (13.32)
High school 87 (12.46)
University ⁄ professional 102 (14.61)
Pack-years smoked (lifetime)
None 379 (54.30)
< 20 153 (21.92)
20–39 101 (14.47)
40+ 55 (7.88)
Missing 10 (1.43)
Waist circumference (cm), Mean (SD) 698, 95.3 (12.1)
Leukocyte fraction (%) Mean ± SD
Neutrophils 57.5 ± 9.14
Lymphocytes 30.8 ± 8.66
Monocytes 7.97 ± 2.13
Eosinophils 3.17 ± 2.11
Basophils 0.55 ± 0.21
Table 2 Probes most closely associated with handgrip strength (natural log kg), with a false discovery rate q-value < 20%
Rank Probe Gene Strength coefficient 95% CI P-value q-value
1 ilmn_1693014 CEBPB 0.20560 0.14 to 0.27 1.03E-06 0.014416
2 ilmn_1772523 TAAR8 1.06986 0.66 to 1.48 2.46E-05 0.123658
3 ilmn_1687652 TGF-b3 1.25827 0.76 to 1.75 3.40E-05 0.13609
4 ilmn_1745583 EXOC1 1.30954 0.78 to 1.84 5.01E-05 0.148728
5 ilmn_1652417 CBWD5 )1.22926 )1.73 to )0.73 5.38E-05 0.150724
6 ilmn_1890206 CA433556–CD40L 1.24223 0.73 to 1.76 7.74E-05 0.171274
7 ilmn_1782050 CEBPD 0.18314 0.11 to 0.26 9.67E-05 0.182561
Models adjusted for age; gender; lifetime pack-years smoked; waist circumference; education; study site; and proportions of leukocyte cell types plus RNA hybridization
and amplification batch.
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repair in old age (Faulkner et al., 1995). Almost every activity of daily liv-
ing involves lengthening contractions, the majority of which do not
induce injury: with age, however, the increasing numbers of highly
stretch-susceptible fibers place the muscles of older animals and humans
at greater risk (Lynch et al., 2008). A recently published mouse model
with reduced CEBPB expression after muscle injury prevented the transi-
tion from the pro-inflammatory M1- to M2 macrophage-mediated repair
and regeneration phases and resulted in sarcopenia-like loss of muscle
fibers and fibrosis of muscle tissue (Ruffell et al., 2009). Until now, the rel-
evance of this experimental demonstration to muscle strength in people
in vivo was unknown.
We set out to test blood leukocyte–derived gene expression associa-
tions with muscle strength in an adult human population. We found, for
the first time, that increased CEBPB expression was strongly associated
with greater muscle strength in a human population. We suggest that this
is because of increased recruitment of alternatively activated macrophag-
es; that we observe this in peripheral blood leukocytes is not unexpected,
as macrophages naturally form a subset of these. By controlling for the
varying proportions of the leukocytes from the individual samples, the
association between CEBPB expression and muscle strength comes to
light. Circulating monocytes were not found to be associated with muscle
strength; however, the primary source of monocytes during repair are
those already residing in the muscle tissue; thus, the circulating mono-
cytes would not necessarily correlate directly with muscle strength.
C ⁄ EBP-b is a transcription factor playing a role in 16 pathways classified
within the Gene Ontology system (Ashburner et al., 2000); however, we
did not find evidence of deregulation of these general (mostly inflamma-
tory) pathways. We also found no evidence that b-catenin (downstream
effector of Wnt), an alternative potential explanatory pathway influenc-
ing proliferation and differentiation of muscle-residing monocytes
(Polesskaya et al., 2003), is differentially expressed. The most likely
remaining explanation for our finding appears to be that higher CEBPB
expression occurs with more effective M2-macrophage-mediated regen-
eration in muscle tissue; C ⁄ EBP-b is involved in both M1 and M2 expres-
sion profiles. However, additional activation above basal expression, via
CREB, only occurs in M2; IL-10, produced by regulatory macrophages, is
dependent upon C ⁄ EBP-b-mediated transcription (Liu et al., 2003), as is
Arg-1 (produced by wound-healing macrophages; Gray et al., 2005), and
others.
Clearly, further work is needed to confirm that the M2-mediated
regeneration process is indeed the source of the higher CEBPB expression
in our blood-derived RNA samples. The regeneration phase after injury is
relatively lengthy (8 days typically) compared with the initial pro-inflam-
matory phase (2 days), and therefore regeneration-related signaling can
be expected to predominate in population-level studies of participants
unselected with respect to the timing of everyday muscle fiber injury.
C ⁄ EBP-b is a transcription factor, and as such, its specificity of action is
tightly regulated by phosphorylation and competing cofactors. The pre-
cise nature of the promoters that C ⁄ EBP-b binds to and activates (i.e., M1
or M2) is dependent on upstream effectors of CEBPB expression, such as
TGF-b, and on whether C ⁄ EBP-b is partnered with pro-inflammatory co-
factors such as NF-jB or with anti-inflammatory cofactors such as STAT6
(Fig. 1). We found both TGF-b3 and one of the three isoforms of TGFBr2
were significantly associated with measures of strength (P = 3.4*10)5
and P = 0.037, respectively). As TGF-b (produced by macrophages after
phagocytosis of apoptotic cells; Fig. 1b) attenuates pro-inflammatory sig-
nals (Fadok et al., 1998), its up-regulation alongside CEBPB is a further
indication that an enhanced anti-inflammatory (M2) phenotype is advan-
tageous for maintaining muscle strength.
There is high homology between the C ⁄ EBP members; they can form
heterodimers (Kinoshita et al., 1992) and substitute for one another to
rescue functionality (Jones et al., 2002). However, each is separated func-
tionally by their response to stimuli, their location within the nucleus, and
their tissue specificity (i.e., macrophage or muscle cell). C ⁄ EBP-d (which
was also associated with muscle strength in our study) has previously
been shown to reverse the inactivation of PPAR-c (Lai et al., 2008); this
results in the stimulation of fatty acid oxidation, glycolysis, mTOR activa-
tion, and anti-inflammatory actions in macrophages in order to increase
hepatic lipogenesis in the liver and adipose tissue (Sag et al., 2008). This
is attributed to differing ratios of saturated to unsaturated fatty acids in
the blood, which promote either M1 (pro-inflammatory) or M2 (anti-
inflammatory) phenotypes, respectively (Kang et al., 2008; Odegaard
et al., 2008; Schug & Li, 2009). It is therefore interesting that we found a
correlation between CEBPD expression and muscle strength in our cohort.
This may possibly be due to an effect of CEBPD on circulating saturated
Fig. 2 Demonstrating increased CEBPB expression with higher grip strength. Using
a box plot and tertiles of CEBPB expression, the association with grip strength is
clearly visible. CEBPB is split by gender because of the natural disparity in muscle
strength. Note: for those with ‘normal’, mid-tertile, and leukocyte percentages.
CEBPB, CCAAT ⁄ enhancer-binding protein-beta.
Table 3 Regression model–based estimated handgrip strength for men and
women aged 70 and with lymphocyte percentage at mean value (30.8%)
C\EBP-b
expression
tertile
Men Women
Estimated
mean
strength (kg)
95% Prediction
interval (kg)
Estimated
mean
strength (kg)
95% Prediction
interval (kg)
1 35.2 24.1–46.3 20.0 9.1–31.0
2 38.2 37.1–39.4 23.1 22.1–24.0
3 41.2 29.4–53.0 26.0 14.0–37.9
Models adjusted for age; gender; lifetime pack-years smoked; waist
circumference; education; study site; and proportions of leukocyte cell types plus
RNA hybridization and amplification batch.
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fatty acid levels in leaner people, producing a more M2-like response and
better muscle repair. Again, this will require further work to elucidate the
exact mechanism.
Large-scale gene expression studies are confounded by the high vari-
ability between healthy individuals. Results can be affected by a range of
factors from ethnicity to employment, including details of blood sample
storage (Dumeaux et al., 2010), and therefore we have used a collection
procedure designed to stabilize RNA at the point of collection from the
participants’ veins. We found the proportion of different white cell sub-
types to be a significant factor when analyzing CEBPB expression. Owing
to the nature of the investigation (observing increased CEBPB expression
hypothesized to be due to, or involved with the causation of, increased
anti-inflammatory macrophages), it is not surprising that varying propor-
tions of neutrophils (and lymphocytes) between people influence CEBPB
expression; however, we found no evidence of interactions between CE-
BPB expression, leukocyte subtype proportions, and muscle strength. In
addition, the CEBPB expression association with strength was still present
in those with ‘normal-range’ mid-tertile lymphocyte and neutrophil
counts. Neutrophils are upstream of macrophages; they are involved
in the initial recruitment to sites of muscle injury and amplify the chain
of events leading to successful resolution of damage (Tidball, 2005;
Tidball & Villalta, 2010).
Along with C ⁄ EBP-b, C ⁄ EBP-d, and TGF-b, 4 other probes were associ-
ated (genome-wide) with grip strength. These were trace amine-associ-
ated receptor 8 (TAAR8), EXOcyst Complex component 1 (EXOC1),
COBW domain-containing protein 5 (CBWD5), and cell-surface receptor
40 ligand (CD40L). CD40L is associated with neutrophil count and has
previously been described to be involved in inflammation (Borcherding
et al., 2010). TAAR8 is a receptor for trace amines that are important in
neuronal function (Lindemann et al., 2005). EXOC1 and CBWD5 are pro-
teins necessary for exocytic vesicle targeting (Andersen & Yeaman, 2010)
and neurotransmission, respectively. CD40L may therefore play a role in
M1 macrophage activation, while the remaining genes may reflect
improved motor neuron function in people with better muscle strength.
A simple association between CEBPB expression and muscle strength
would be of limited interest without evidence that CEBPB expression is
also associated with everyday functioning, impairment, and disability.
Lower handgrip muscle strength in 45- to 68-year-old men in the Hono-
lulu Heart Program was predictive of disability 25 years later (Rantanen
et al., 1999). The SPPB score is a well-validated and widely used objective
measure of functional impairment and is predictive of subsequent disabil-
ity and mortality (Guralnik et al., 1995). Our finding of an association
between higher CEBPB expression and a markedly lower risk of impair-
ment on the SPPB suggests that our findings may be of clinical and practi-
cal significance.
Given the mouse model demonstrating that increased CEBPB expres-
sion is necessary for muscle regeneration, it is plausible that the CEBPB
expression associations reported here with muscle strength reflect a
causal relationship, although the statistical association may theoretically
reflect an effect rather than a cause. As noted, future work is needed
to confirm that higher CEBPB expression in peripheral blood–derived
samples does indeed reflect greater M2-macrophage-mediated muscle
repair. Studies of responses to experimentally induced muscle stresses
could chart the temporal response from early reaction to injury
through to the later repair phases in people of different ages and
strengths. It may be possible to explore the effects of polymorphisms
(SNPs) in the implicated genes on expression and strength. Eventually,
experimental approaches to enhance CEBPB pathway expression and
related repair may provide a means of protecting and enhancing aging
muscle.
Conclusion
We have presented the first report of the association between raised
CEBPB expression in vivo and greater muscle strength in humans. This may
be consistent with mouse model findings that C ⁄ EBP-b signaling is critical
for the regeneration of muscle fibers after injury. TGF-b, a key initiator and
cofactor, is also up-regulated. CEBPB expression is also associated with
functioning on the SPPB score. Independent replication and mechanistic
studies linking CEBPB expression in leukocytes to muscle are needed.
Experimental procedures
Samples
InCHIANTI (Ferrucci et al., 2000) is a population-based prospective study
in the Chianti area (Tuscany) of Italy. The participants were enrolled in
1998–2000 and were interviewed and examined every 3 years. Ethical
approval was granted by the Instituto Nazionale Riposo e Cura Anziani
institutional review board in Italy. Participants gave informed consent to
participate.
RNA collection, extraction, and
the whole-transcriptome scan
Peripheral blood specimens preserving in vivo RNA expression were
collected in 2008–2009 from 733 participants. RNA was extracted
from peripheral blood samples using the PAXgene Blood mRNA kit
(Qiagen, Crawley, UK) according to the manufacturer’s instructions.
This ensures the transcript expression is as near to its in vivo levels as
possible (Debey-Pascher et al., 2009). Whole-genome expression pro-
filing of the samples was conducted using the Illumina Human HT-12
microarray (Illumina, San Diego, CA, USA) as previously described
(Zeller et al., 2010). Data processing was performed using the Illu-
mina and Beadstudio software (Illumina) as previously described (Zel-
ler et al., 2010). All microarray experiments and analyses complied
with MIAME guidelines. Data from 698 individuals and 16 571
probes passed our quality control process; 12 subjects were excluded
on the basis that their mean signal intensities across all probes with
P £ 0.01 were > 3 standard deviations from the cohort mean; probes
with < 5% of subjects giving intensities with P ‡ 0.01 different from
background were also excluded.
Handgrip strength
Maximum handgrip strength was measured using a grip dynamometer,
recording the maximum force generated (kg) during two attempts with
each hand. In our analysis, we used the participant’s highest measured
grip strength for either hand.
Statistical analysis
Expression data were available for 707 individuals. Seven individuals were
excluded following subject-level QC steps, where all intensity data were
missing or ± 3 standard deviations from the mean (leaving 698 individu-
als). The relationship between gene expression and handgrip and other
muscle strength was tested mainly using linear regression models with
natural log-transformed gene expression level as the dependent variable.
Separate regression models were fitted for each of the 16 571 expressed
probes. We used the FDR to account for multiple testing. R (statistical
computing language) v2.8.1 (The R Foundation for Statistical Computing,
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Vienna, Austria) was used for large-scale analyses and STATA v10.1 (Tim-
berlake Consultants, London, UK) for confirmation and additional
exploration.
Regression models were adjusted for potential confounding factors
on gene expression: age; gender; lifetime pack-years smoked (in five
categories: none, less than 20, 20–39, 40 plus years, and missing);
waist circumference (as a continuous trait); highest level of educa-
tion attained (in five categories: none, elementary, secondary, high
school, and university ⁄ professional); study site [individuals were
drawn from a rural village (Greve) and an urban population (Bagno
a Ripoli)]; and the proportion of leukocyte cell types (neutrophil %,
lymphocyte %, monocyte %, eosinophil %). We also controlled for
potential hybridization and ⁄ or amplification batch effects in all our
analyses.
The SPPB score is a summary of performance on walk speed, time to
stand up from the sitting position several times (chair stands), and graded
balance tests (Vasunilashorn et al., 2009), and SPPB scores are predictive
of disability progression and mortality. Physical activity was classified
based on the metabolic equivalent (Ainsworth et al., 1993) approach
into: hardly any activity; mostly sitting ⁄ some walking; light exercise 2–
4 h per week; moderate 1–2 h or light > 4 h per week; moderate exer-
cise > 3 years per week; intense exercise many times per week; and
walks 5+ km per day, 5+ days per week.
TaqMan low-density array (TLDA) validation of
microarray results
We selected a subsample of 100 male subjects with middle tertile
lymphocyte percentages for validation of the CEBPB expression data.
Total RNA (30–170 ng) was reversed transcribed in 20-lL reactions
using the Superscript III VILO kit (Invitrogen, Paisley, UK), according
to the manufacturer’s instructions. CEBPB expression levels for each
target transcript were then measured using the TLDA platform
(Applied Biosystems, Foster City, CA, USA), using commercially avail-
able assay CEBPB-Hs00942496_s1. Reaction mixes contained 50 lL
2· TaqMan universal master mix (no AMPerase; Applied Biosystems),
30 lL dH2O, and 20 lL cDNA template. Cycling conditions were
50C for 2 min, 94.5C for 10 min followed by 50 cycles of 97C for
30 s and 57.9C for 1 min. CEBPB expression was measured in tripli-
cate for each sample. Relative gene expression levels were calculated
using the comparative Ct technique (Applied Biosystems, 2001) using
the StatMiner relative quantification software developed for analysis
of TLDA plates (Integromics, Granada, Spain). Gene expression levels
were calculated relative to the geometric mean of the three genes –
COQ2, NFKB1, and TNF – whose transcript expression was most sta-
ble across all samples, as identified by the GeNorm function of the
STATMINER software (Integromics).
Gene set enrichment analysis
Gene set enrichment analysis (GSEA) is an alternative method of ana-
lyzing RNA expression data, in which gene sets are specified by the
user (can be custom or downloaded from the GSEA site) and the
association across the whole set of genes (usually related functionally)
is tested against a phenotype (Mootha et al., 2003; Subramanian
et al., 2005). We downloaded the 16 Gene Ontology (Ashburner
et al., 2000) pathways in which CEBPB is involved, which included
‘inflammatory response’, ‘defense response’, ‘response to stress’, and
‘RNA metabolic process’. See Harries et al. (2011) for detailed
methods.
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